Format

Send to

Choose Destination
Science. 2011 Jun 24;332(6037):1519-23. doi: 10.1126/science.1204265.

Human fatty liver disease: old questions and new insights.

Author information

1
Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390-9046, USA.

Abstract

Nonalcoholic fatty liver disease (NAFLD) is a burgeoning health problem that affects one-third of adults and an increasing number of children in developed countries. The disease begins with the aberrant accumulation of triglyceride in the liver, which in some individuals elicits an inflammatory response that can progress to cirrhosis and liver cancer. Although NAFLD is strongly associated with obesity and insulin resistance, its pathogenesis remains poorly understood, and therapeutic options are limited. Here, we discuss recent mechanistic insights into NAFLD, focusing primarily on those that have emerged from human genetic and metabolic studies.

PMID:
21700865
PMCID:
PMC3229276
DOI:
10.1126/science.1204265
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center